| Dr Lisa Valdene Thompson, DDS | |
|
1450 Mercantile Ln, Suite 207a, Largo, MD 20774-5376 | |
| (240) 455-7484 | |
| (240) 455-7476 |
| Full Name | Dr Lisa Valdene Thompson |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 1450 Mercantile Ln, Largo, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568512242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 13668 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Valdene Thompson, DDS 1450 Mercantile Ln, Suite 207a, Largo, MD 20774-5376 Ph: (240) 455-7484 | Dr Lisa Valdene Thompson, DDS 1450 Mercantile Ln, Suite 207a, Largo, MD 20774-5376 Ph: (240) 455-7484 |
News Archive
It was on a cold, sunny day in Baltimore last January that Curt Kwak, chief information officer of the Washington Health Benefit Exchange, first realized that the signature feature of President Obama's Affordable Care Act could be in trouble.
Products that are "biosimilar" or interchangeable with a licensed biological product hold considerable promise for the treatment of a variety of medical conditions such as rheumatic diseases, and possibly at a reduced cost.
Artificial sweeteners may be associated with long-term weight gain and increased risk of obesity, diabetes, high blood pressure and heart disease, according to a new study published in CMAJ
Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted a Breakthrough Therapy designation to cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor replacement therapy for the treatment of patients with molybdenum cofactor deficiency type A, a severe and life-threatening, ultra-rare, genetic metabolic disorder that causes catastrophic and irreversible neurologic damage within the first weeks of life.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) announced today the Korean Food & Drug Administration (KFDA) has approved RPC's Onko-Sure™ in Vitro Diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea.
› Verified 6 days ago
Dr. William Matthew Woods Jr., Dentist Medicare: Not Enrolled in Medicare Practice Location: 932 Largo Center Dr, Largo, MD 20774 Phone: 301-322-8900 | |
Chibueze George Okoro, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1400 Mercantile Ln Ste 100, Largo, MD 20774 Phone: 301-925-8600 Fax: 301-925-8065 | |
Dr. William H. Woodward Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 932 Largo Center Dr, Largo, MD 20774 Phone: 301-322-8900 Fax: 301-322-2840 | |
Dr. Robert K Mensah, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1401 Mercantile Ln Ste 102, Largo, MD 20774 Phone: 301-773-7703 Fax: 301-773-7708 | |
Felix Papillon, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 9701 Apollo Dr Ste 109, Largo, MD 20774 Phone: 301-773-5700 Fax: 301-773-1515 | |
Dr. Monica F Tiu Silva, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1220 Caraway Ct Ste 1050, Largo, MD 20774 Phone: 301-494-3000 Fax: 301-494-3333 |